Brandenburg Kapital - News - Thomas Krause supports startups and tech firms.
Life sciences and artificial intelligence currently offer enormous potential
Potsdam, March 2026 - The life sciences and biotech industry is one of the most innovative growth sectors in Europe. In this interview, a managing director of Brandenburg Kapital GmbH - Thomas Krause, discusses developments in the European biotech ecosystem, the financing situation for start-ups, and opportunities for young life sciences companies in the Berlin-Brandenburg region.
As the venture capital company of the Investment Bank of the State of Brandenburg (ILB), Brandenburg Kapital is one of the most important investors for technology-oriented start-ups in the region and supports numerous companies in the fields of biotechnology, medical technology, and life sciences on their growth path. Click here to see Brandenburg Kapital's portfolio companies in the life sciences sector.
Exchange with international investors and innovative start-ups is also a central component of the industry event bio:cap, which will take place from June 9 to 11, 2026, at CityCube Berlin. Brandenburg Kapital will also be there as an investor, seeking dialogue with founders and partners from the life sciences community.
Read the full interview:
About Brandenburg Kapital/ ILB
Brandenburg Kapital GmbH is a subsidiary of the Investment Bank of the State of Brandenburg (ILB). Since 1993, it has been supporting Brandenburg-based companies as the venture capital arm of ILB by acquiring equity interests and making equity-like investments. As a public venture capital company, experienced lead investor, and active partner, Brandenburg Kapital ensures a strong equity base for start-ups and small and medium-sized enterprises in the state of Brandenburg on the basis of a stable corporate environment. The equity fund currently has around €100 million available for this purpose. The funds for the Brandenburg Kapital fund, which was established on behalf of the Brandenburg Ministry of Economic Affairs, are currently provided from the European Regional Development Fund and the ILB's own resources.
